PRGO Share Price

Open 83.73 Change Price %
High 84.50 1 Day -0.02 -0.02
Low 83.61 1 Week -0.40 -0.47
Close 84.07 1 Month 12.15 16.89
Volume 1394871 1 Year -42.19 -33.42
52 Week High 140.65
52 Week Low 71.84
PRGO Important Levels
Resistance 2 84.90
Resistance 1 84.56
Pivot 84.06
Support 1 83.58
Support 2 83.24
NASDAQ USA Most Active Stocks
NVDA 100.49 -9.27%
JBHT 97.31 -1.05%
AREX 2.96 -1.99%
OZRK 55.54 1.02%
FNSR 34.15 0.12%
AGNC 19.64 0.72%
EA 86.65 -0.84%
FNFG 10.18 -0.20%
PRFZ 118.04 -0.80%
DELL 13.86 0.22%
More..
NASDAQ USA Top Gainers Stocks
ECTE 0.18 50.00%
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
ZAZA 0.06 20.00%
JAKK 5.70 12.87%
LINE 0.18 12.50%
More..
NASDAQ USA Top Losers Stocks
DEER 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
More..

Perrigo Company (NASDAQ: PRGO)

PRGO Technical Analysis 2
As on 23rd Feb 2017 PRGO Share Price closed @ 84.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 92.96 & Buy for SHORT-TERM with Stoploss of 80.92 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRGO Target for February
1st Target up-side 84.67
2nd Target up-side 90.65
3rd Target up-side 96.62
1st Target down-side 67.63
2nd Target down-side 61.65
3rd Target down-side 55.68
PRGO Other Details
Segment EQ
Market Capital 10823602176.00
Sector Healthcare
Industry Drug Related Products
Offical website http://www.perrigo.com
PRGO Address
PRGO
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 604 0031
Interactive Technical Analysis Chart Perrigo Company ( PRGO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Perrigo Company
PRGO Business Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. Its businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia. In February 2013, it completed the acquisition of Leeds, United Kingdom-based Rosemont Pharmaceuticals Ltd. In April 2013, it closed the acquisition of Velcera, Inc. In June 2013, the Company acquired an ophthalmic sterile ointment and solution product portfolio from Fera Pharmaceuticals, LLC. In December 2013, it acquired Elan Corporation Plc.